Sandoz Abandons US Development of Rixathon
Chloé Thépaut, MRes, Oncology Senior Analyst, GlobalData, examines the implications of Sandoz’s abandoned attempt to...
Chloé Thépaut, MRes, Oncology Senior Analyst, GlobalData, examines the implications of Sandoz’s abandoned attempt to...
In the latest Industry Viewpoint, Howard Fingert speaks to CTA’s Elizabeth Williams about the challenges...
In this Industry Viewpoint, CTA’s Elizabeth Williams speaks with Philip Arlen to discuss key considerations...
As medicinal cannabis hits the U.K., CTA’s Harry Parsons takes a look at the ground-breaking...
Chloé Thépaut, MRes, Oncology Senior Analyst, GlobalData, examines the importance of the EMA’s efforts to...
CTA highlights the best articles from the month of September 2018
Jennifer Brandl, Clinical Trial Manager, Kezar Life Sciences, addresses a key hurdle to overcome to...
Robert Greene, Founder and President, HungerNdThirst Foundation and Professional Patient, explains why patients should have...
Peter Orosz, Head of Clinical Supply Chain Management & Oncology, Boehringer Ingelheim, addresses the challenges...
Fern Barkalow, PhD, Oncology and Hematology Director, GlobalData, explores the future of biosimilars in light...